WAVE LIFE SCIENCES LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.675 USD | +0.98% |
|
-0.73% | +13.03% |
| May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 | |
| May. 09 | Earnings Flash (WVE) WAVE LIFE SCIENCES USA Posts Q1 Revenue $12.5M, vs. Street Est of $23M | MT |
Chart calendar Wave Life Sciences Ltd.
4d892e20731736bcab9ea15879.OYNqPYlUK0eT3_9TnNdl1AXKoBUN8zN_DDheTN7LA8o.SNktasphYgLhhpsJ6adXmzakl3BOh19LPggLKpmYUqRf5FsEvnlbDsHpnA~2e136edcc60d576a5a28e95b05551bf2
Upcoming events on Wave Life Sciences Ltd.
Past events on Wave Life Sciences Ltd.
| 2024-05-10 04:30 pm | American Society of Gene & Cell Therapy Meeting |
| 2024-05-09 12:00 pm | American Society of Gene & Cell Therapy Meeting |
| 2024-05-09 08:30 am | Q1 2024 Earnings Call |
| 2024-05-09 07:30 am | Q1 2024 Earnings Release |
| 2024-04-11 08:45 am | Needham Healthcare Conference |
| 2024-04-03 03:10 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 2024-03-06 08:30 am | Q4 2023 Earnings Call |
| 2024-03-06 07:30 am | Q4 2023 Earnings Release |
| 2024-03-04 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #M168 |
| 2024-03-03 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #S10 |
| 2024-03-03 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #S14 |
| 2024-01-10 06:00 pm | JPMorgan Healthcare Conference |
| 2023-11-29 03:50 pm | Evercore ISI HealthCONx Conference |
| 2023-11-09 08:30 am | Q3 2023 Earnings Call |
| 2023-11-09 07:30 am | Q3 2023 Earnings Release |
| 2023-10-02 10:30 am | Chardan Genetic Medicines Conference |
| 2023-09-28 10:00 am | R&D Day |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-03 08:30 am | Q2 2023 Earnings Call |
| 2023-08-03 07:30 am | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,0 18,9 -15.62% | 20,1 20,5 -1.98% | 41,0 52,7 -22.27% | 3,65 4,80 -24.03% | 113 104 8.9% | 87,0 |
|
EBITDA Million USD | Released Forecast Spread | -199 -196 -1.61% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -208 -201 -3.68% | -153 -150 -2.26% | -127 -121 -5.11% | -163 -157 -3.4% | -68,0 -79,7 14.72% | -137 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -194 -188 -3.14% | -151 -148 -2.15% | -122 -117 -5.03% | -161 -156 -3.62% | -58,2 -70,9 17.97% | -127 |
|
Net income Million USD | Released Forecast Spread | -194 -188 -3.14% | -150 -148 -1.58% | -122 -115 -6.02% | -162 -156 -3.58% | -57,5 -65,3 11.91% | -119 |
|
EPS USD | Released Forecast Spread | -5,72 -5,53 -3.36% | -3,82 -3,84 0.62% | -2,36 -2,22 -6.17% | -2,05 -2,01 -1.91% | -0,54 -0,62 12.67% | -0,88 |
| Announcement Date | 02/03/20 | 04/03/21 | 03/03/22 | 22/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,75 3,86 -54.63% | 0,38 3,00 -87.5% | 0,29 5,40 -94.72% | 1,24 2,40 -48.34% | 12,9 38,6 -66.51% | 22,1 7,94 178.5% | 49,2 23,4 110.03% | 29,1 19,8 46.56% | 12,5 25,0 -49.85% | 19,4 | 16,9 | 16,9 | 15,0 | 14,2 |
|
EBIT Million USD | Released Forecast Spread | -38,1 -35,4 -7.68% | -42,2 -35,2 -19.62% | -38,9 -40,2 3.15% | -43,6 -38,2 -13.93% | -30,3 -1,35 -2147.08% | -23,5 -37,3 37.01% | 4,44 -24,9 117.83% | -18,7 -30,5 38.71% | -34,5 | -35,1 | -35,9 | -37,1 | -40,3 | -36,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,8 -34,4 -9.78% | -41,3 -34,5 -19.8% | -39,0 -39,4 0.92% | -43,0 -37,4 -14.97% | -27,4 -0,61 -4390.78% | -21,1 -36,0 41.45% | 6,58 -23,3 128.17% | -16,3 -29,0 43.93% | -31,6 | -32,8 | -33,5 | -34,7 | -38,4 | -35,0 |
|
Net income Million USD | Released Forecast Spread | -37,8 -33,4 -13.2% | -41,3 -33,8 -22.08% | -39,0 -39,2 0.43% | -43,7 -38,1 -14.61% | -27,4 -6,07 -351.62% | -21,1 -34,9 39.5% | 7,00 -18,9 137.11% | -16,3 -23,9 31.96% | -31,6 | -32,8 | -31,3 | -32,3 | -38,5 | -35,0 |
|
EPS USD | Released Forecast Spread | -0,62 -0,56 -11.71% | -0,62 -0,54 -15.17% | -0,42 -0,50 15.44% | -0,45 -0,41 -9.76% | -0,27 -0,04 -575% | -0,20 -0,33 39.66% | 0,07 -0,18 139.25% | -0,15 -0,23 33.82% | -0,24 | -0,24 | -0,23 | -0,23 | -0,27 | -0,22 |
| Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 03/05/23 | 03/08/23 | 09/11/23 | 06/03/24 | 10/05/24 | - | - | - | - | - |
| 2024-05-13 | IMMATICS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 2024-05-13 | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
| 2024-05-13 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-14 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
Past sector events for Wave Life Sciences Ltd.
| Today | PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release |
| Today | ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected) |
| Today | LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release |
| Today | PEPTRON, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- WVE Stock
- Calendar Wave Life Sciences Ltd.